- Home
- ATRA vs ECOR Comparison
ATRA vs ECOR Comparison
Compare ATRA & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRA | ECOR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.2M | 85.6M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ATRA | ECOR |
|---|---|---|
| Price | $9.70 | $11.67 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $5.00 | ★ $18.00 |
| AVG Volume (30 Days) | 42.1K | ★ 78.9K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.52 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,772,000.00 | $32,032,000.00 |
| Revenue This Year | N/A | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $3.92 | $4.41 |
| 52 Week High | $19.15 | $11.93 |
Technical Indicators
Market Signals| Indicator | ATRA | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 53.26 | 70.56 |
| Support Level | $8.98 | $5.70 |
| Resistance Level | $10.02 | N/A |
| Average True Range (ATR) | 0.69 | 0.67 |
| MACD | 0.00 | 0.14 |
| Stochastic Oscillator | 34.26 | 83.90 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.